Artikel Review: Intermediate Product Sampling Pattern Planning in the Validation Process

Main Article Content

Ayu Nursiti Fatimah


The pharmaceutical industry must be able to ensure certainty in the production process through validation throughout the production process. Therefore, it is necessary to carry out process validation to ensure that every parameter and procedure used in each intermediate product production process obtains results that meet the requirements and specifications required. A sample is one of the guidelines in conducting process validation, so it is necessary to plan to determine the collection location based on risk and scientific reasons. This review aims to provide information on the tools used during the sampling process and the number of sample points taken on solid, semi-solid, and non-sterile liquid drug product preparations. Hopefully, this review can be a consideration for the pharmaceutical industry in planning sampling for the intermediate product during process validation. The method used is a library search from databases available online from ScienceDirect and standards from authoritative institutions. The results obtained in this review are tools that can be used in sampling patterns for solid preparations, namely thief samplers, simple bag-sampling spears, and scoop and for liquid and semi-solid non-sterile preparations, dip tubes and weighted containers. In the sampling pattern during the mixing process of the solid, there are 10 locations of sampling. While in the sampling pattern during the process of mixing liquid and semi-solid non-sterile, there are 9 locations of sampling. With this validity, it can represent the consistency of product quality.

Article Details

How to Cite
Fatimah, A. N., & Muchtaridi, M. (2023). Artikel Review: Intermediate Product Sampling Pattern Planning in the Validation Process. Journal of Pharmaceutical and Sciences, 6(1), 292–300.
Review Article


A, Nash R., and Wachter AH. 2003. Pharmaceutical Process Validation. 3rd ed. New York: Marcel Dekker.

Aleem, H., Y. Zhao, S. Lord, T. McCarthy, and P. Sharratt. 2003. “Pharmaceutical Process Validation: An Overview.” Proceedings of the Institution of Mechanical Engineers, Part E: Journal of Process Mechanical Engineering 217(2):141–51. doi: 10.1243/095440803766612801.

Anon. 2007. “Recommendations on Validation Master Plan, Installation and Operational Qualification, Non-Sterile Process Validation, Cleaning Validation.” I J P R N.

Anon. n.d. Quality Assurance of Pharmaceuticals: A Compendium of Guidelines And Related Materials. 105th ed.

Anon. n.d. Quality Management System – Process Validation Guidance GHTF/SG3/N99-10:2004. 2nd ed.

Bhattacharjee, D., S. MaitY, and A. Manna. 2013. “Industrial Application of Process Validation in the Development and Scale-Up of Pharmaceutical Tablet Dosage Form of a Low Dose Containing Drug and a High Dose Containing Drug.” J P S T 3(3):570–73.

Bodnar, Małgorzata, Jacek Namieśnik, and Piotr Konieczka. 2013. “Validation of a Sampling Procedure.” TrAC - Trends in Analytical Chemistry 51(November 2018):117–26. doi: 10.1016/j.trac.2013.06.011.

BPOM RI. 2012. Petunjuk Operasional Penerapan Pedoman Cara Pembuatan Obat Yang Baik 2012 Jilid II. Jakarta: BPOM RI.

BPOM RI. 2018. Pedoman Cara Pembuatan Obat Yang Baik. Jakarta: BPOM RI.

Bt., Dietrick JM, and Loftus. n.d. Regulatory Basis for Process Validation. edited by 3rd. United States.

C, Oechslein, and Lazar M. S. 2012. “Rocess Validation from View Report of the FDA, Maas & Peither AG – GMP Publishing.” LOGFILE, 3.

Center for Drug Evaluation and Research. 2008. “Guidance for Industry on General Principles and Practices of Process Validation.”

Department, U. S., Food and Drug of Health and Human Services, Centre for Drug Evaluation and Administration, Centre for Biologics Evaluation Research (CDER), Centre for Veterinary and Research (CBER), and Medicine (CVM). 2011. “Guidance for Industry: Process Validation: General Principles and Practices.”

E, Jatto, and Okhamafe AD. 2022. “An Overview of Pharmaceutical Validation and Process Controls in Drug Development.” Tropical Journal of Pharmaceutical Research 1(2):117.

Edelman, Alexandra, John Grundy, Sarah Larkins, Stephanie M. Topp, David Atkinson, Regional Training, Hub Lead, Bhavini Patel, Edward Strivens, Older Persons, Subacute Services, Nishila Moodley, Maxine Whittaker, Veterinary Sciences, Top End, Health Service, Royal Darwin Hospital, Rocklands Drive, and Hinterland Hospital. 2020. “Review Article Abstract : Full Article :” 20(4).

Evans, P. K. 1998. “Streamlining Validation.” Pharmaceutical Technology Europe 10(12):48–52.

FDA Guidance for Industry. 2004. Standard Operating Procedures CGMP. United States: Food and Drug Administration.

FDA Guidelines on General Principles of Process Validation. 1987. “Division of Manufacturing and Product Quality.”

Gupta, G. D., R. Garg, and S Aggrwal. 2008. “Guidelines on General Principles of Validation: Solid Liquid and Sterile Dosage Forms,.” 6(1):28–33.

H.S Pahuja. 2015. . “. A Review on Pharmaceutical Process Validation.” International Journal of Pharmacy 3(7):56–58.

H, Kaur, Singh G, and Seth N. 2013. “Pharmaceutical Process Validation: A Review.” JDDT 3(4).

Industry, Guidance for. n.d. “Process Validation: General Principles and Practices.” 2011.

Inspectorate, Health Canada /. Health Products and Food Branch. 2009. “Validation Guidelines for Pharmaceutical Dosage Forms.”

ISO 3951. 1999. “Sampling Procedures for Inspection by Attributes.”

J, Satyabrata, Arjun G, and Ravipati A. K. 2010. “Industrial Process Validation of Solid Dosage Forms.” Overview Int. J. Pharma Sci Rev And Res 4(2):145–48.

K, Harpreet, S. Gurpreet, and S. Nimrata. 2013. “Pharmaceutical Process Validation : A Review.” Journal of Drug Delivery and Therapeutics 3(4):189–94.

Kathiresan k, Moorthi C, Prathyusha Y, and B. Gade. 2014. “An Overview of Pharmaceutical Validation; Research Journal of Pharmaceutical.” Biological and Chemical Sciences; ISSN: 0975-8585 1(4).

Kavita, Khurana G, and Chaudhary S. 2013. “Process Validation of Solid Dosage Form: A Review.” Pharma Science Monitor, An International Journal of Pharmaceutical Sciences 4(4):390–91.

Kumar, Kotha Arun, and N. Vishal Gupta. 2015. “Handling of out of Specification Results.” International Journal of Pharmaceutical Quality Assurance 6(2):38–44.

Levy, P. S., and S. Lemeshow. 2013. “Sampling Of Popilations: Methods and Applications.” John Wiley & Sons.

Loftus BT. 1984. “The Regulatory Basis for Process Validation. Pharmaceutical Process Validation.”

M Sharma, and S. Agarwal. 2015. “Prospective Validation: A Review.” The Pharma Innovation 4(3):1–7.

Napoli, C., Marcitrigiano, V., and M. T. Montagna. 2012. “Air Sampling Procedures to Evaluate Microbial Contamination: A Comparison between Activea and Passive Methods in Operatiob Theaters.” BMC Pub Health. 12(1):594.

Oechslein, C., and M. S Lazar. 2012. “Process Validation from View Report of the FDA, Maas & Peither AG – GMP.”

Palinkas, L. .., S. .. Howirtz, C. .. Green, J. .. Wisdom, N. Duan, and K. Hoagwood. 2015. “Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research.” Pol. Ment. Health Serv. . Res. 42(5):533.

Pandita, R., AC Rana, Seth N, and Bala R. 2012. “Introduction and General Overview of Pharmaceutical Process Validation A Review.” International Research Journal of Pharmacy 3(6).

Pharmaceutical Dosage Form – Saudi Food & Drug Authority. 1992. “Guidelines for Process Validation of Pharmaceutical Dosage Form.”

Practice., South African Guide to Good Manufacturing. 1996. “Pretoria: Medicines Control Council.”

Products, The European Agency for the Evaluation of Medicinal. 2001. “Guidelines on Process Validation.”

Rajpal, Govind, Rajeshwar Kamal Kant Arya, and Nitin Kunwar. 2016. “Basic Concept of Process Validation in Solid Dosage Form (Tablet): A Review.” Journal of Drug Delivery and Therapeutics 6(4):79–87. doi: 10.22270/jddt.v6i4.1282.

Ramsey, M. H. 1998. “Sampling as a Source of Measurement Uncertainty: Techniques for Quantification and Comparision with Analytical Sources.” J . Anal Atomic Spectrom. 13:97–104.

Ramsey, M. H., and A. Argyraki. 1997. “Estimation of Measurement Uncertainty Form Field Sampling: Implications for the Classification of Contaminated Land.” Sci. Total Environ 198:243–57.

RR, Parajuli, Shrestha S, Lamichane S, and Pokhrel P. 2015. “A Review on Pharmaceutical Process Validation of Solid Dosage Form [Tablets].” Journal of Drug Delivery and Therapeutics 5(6):1–7.

Sayeed, Shaziya Y., and Anju Goyal. 2017. “Pharmaceutical Process Validation Approach for Extended Release Tablets: An Overview.” The Pharmaceutical and Chemical Journal 4(4):9–19.

Sharma, Sumeet, and Gurpreet Singh. 2013. “Process Validation in Pharmaceutical Industry; an Overview.” Journal of Drug Delivery and Therapeutics 3(4):184–88. doi: 10.22270/jddt.v3i4.582.

Thaduvai, Raveendranath, Bodavula Samba Siva Rao, and M. Jeybaskaran. 2012. “Process Validation of Pantoprazole 40mg Tablets.” The Pharma Innovation 1(5):47–62.

U.S. Food and drug administration. 2015. “Guide to Inspections of Oral Solid Dosage Forms Pre/ Post Approval Issue for Development and Validation.”

Wei, Xiaolin, Zhitong Zhang, Joseph P. Hicks, John D. Walley, Rebecca King, James N. Newell, Jia Yin, Jun Zeng, Yan Guo, Mei Lin, Ross E. G. Upshur, and Qiang Sun. 2019. “Long-Term Outcomes of an Educational Intervention to Reduce Antibiotic Prescribing for Childhood Upper Respiratory Tract Infections in Rural China: Follow-up of a Cluster-Randomised Controlled Trial.” PLoS Medicine 16(2):1–20. doi: 10.1371/journal.pmed.1002733.

WHO Technical Repor. 2014. Guidelines on the Validation of Manufacturing.

Zameeruddin, M., SS Kale, SB Jadhav, VS Kadam, Kadam VS Zameeruddin M, Kale SS, Jadhav SB, and Chaware SS. 2015. “Process Validation of Oral Solid Dosage Form: Tablet – An Overview.” World Journal of Pharmacy and Pharmaceutical Sciences 4(12):358–73.